Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
so we'll no doubt be red today.
Thank you, HH. I stand (happily) corrected.
PS I am not Stu.
No need for that. The contact email for UK is not on the 'contact us' page of their website. At least it didn't appear on my laptop. There's an email for the US office only. So, if you have the contact email just post it and we'll get an answer to an important question.
If anyone can post a contact email I'll ask the company directly.
TY. Seems that an RNS was appropriate given the two previous RNS announcements.
I am interested because I think the IND submission could be more distant than many here assume. It looks like a stringent process involving much more than PQ runs. Any further info would be gratefully appreciated.
HFH, thank you but I am aware of that RNS. I AM an investor here.
My question was driven by a look into the IND process and there's a lot more to it than 3 PQ runs. Seemed to me the pre-IND meeting would be a fairly important step. An online meeting is still a meeting, but was never announced.
Additional. I was going to email the company to ask this simple question but could find no email address on their website.
Announced RNS 13/12/21
Deferred due to COVID to May 2022 - RNS 16/2/22
Nothing further since then. Comments/info
TY
Amazing company! PHC has been working for over a decade to bring its agricultural products to market, but NNN manages it in a few tweets.
TY bald eagle. Has anyone any info on African resources? Seems a bit dodgy. Happy to be proven wrong.
Just read back thru the chat here and RetiredBanker back on 31JAN22 states the Assaubayev family hold 70% of the stock. Can anyone explain this? Are they in fact African Resources?
Seems odd. Any opinions?
Also, looked up African Resources and viewing the RNS back in 2012. Can't get much info on this deal or the company.. Anyone?
From 3FEB RNS - £100 was from iCCAMT not the BOD
Commenting, Dr Hui Wu, CEO and Founder of iCCAMT said:
"This agreement represents a significant opportunity to bring early and cost-effective cancer detection to the people of China. It is estimated that about 95.8 million people in China have a high risk of lung cancer and if screening was performed every three years, then more than 30 million tests per year would be required. At a target price of about £100 per test, the total available market for tests based on the CIZ1B biomarker would be £3 billion.
I'm a holder here but where does this £100 per test come from. I've never seen it quoted. Thanks in advance.
Seems like good news. Anyone care to explain just how good?
MCAP £29m. What's not to like.
... makes a catchier headline.
https://www.dailymail.co.uk/sciencetech/article-11132485/Holy-grail-trialled-NHS-save-thousands-lives-detecting-cancer-symptoms-show.html
LOL, I appreciate the tips and will look into them this weekend. TheOracle, have a beer and chill.
Hope no one will object, but while we're waiting here maybe we could share some tips on similar companies (any sector) that could be set up for massive growth. Fortune makers, so to say.
I only have one; PHC
Eqtec yesterday. Ciz today. maybe I'm not the utter loser I thought. Lets hope we now get the reversal we deserve. £4m. What an utter joke.